Opioid overdose prevention with intranasal naloxone among people who take methadone
Abstract
Overdose education and naloxone distribution (OEND) is an intervention that addresses overdose, but has not been studied among people who take methadone, a drug involved in increasing numbers of overdoses. This study describes the implementation of OEND among people taking methadone in the previous 30 days in various settings in Massachusetts. From 2008 to 2010, 1553 participants received OEND who had taken methadone in the past 30 days. Settings included inpatient detoxification (47%), HIV prevention programs (25%), methadone maintenance treatment programs (MMTP) (17%), and other settings (11%). Previous overdose, recent inpatient detoxification and incarceration, and polysubstance use were overdose risks factors common among all groups. Participants reported 92 overdose rescues. OEND programs are public health interventions that address overdose risk among people who take methadone and their social networks. OEND programs can be implemented in MMTPs, detoxification programs, and HIV prevention programs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The intranasal route of administration has been validated for both oxytocin and naloxone in previous human studies.
“This route of administration has been validated for both OT (6, 71) and NAL (72–74) in previous human studies”
From Oxytocin under opioid antagonism leads to supralinear enhancement of social attention (2017) · cites this paper as [73]
Cites
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192 · see citing works
Release from prison–a high risk of death for former inmates
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064115 · Cited by 1,684 · see citing works
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654 · see citing works
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s63 · Cited by 642 · see citing works
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s5 · Cited by 430 · see citing works
Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study
Strang, J., McCambridge, J., Best, D. W., Beswick, T., Bearn, J., Rees, S., & Gossop, M. (2003) · BMJ · doi:10.1136/bmj.326.7396.959 · Cited by 339 · see citing works
Degenhardt, L. J., Randall, D., Hall, W., Law, M. G., Butler, T. G., & Burns, L. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.05.021 · Cited by 337 · see citing works
Coffin, P. O., Galea, S., Ahern, J., Leon, A. C., Vlahov, D., & Tardiff, K. J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00376.x · Cited by 334 · see citing works
Community-Based Opioid Overdose Prevention Programs Providing Naloxone —United States, 2010
Wheeler, E., Davidson, P. J., Jones, T. S., & Irwin, K. S. (2012) · JAMA · doi:10.1001/jama.307.13.1358 · Cited by 257 · see citing works
Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose
Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.146647 · Cited by 250 · see citing works
Seal, K. H. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti053 · Cited by 244 · see citing works
Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths
Maxwell, S., Bigg, D., Stanczykiewicz, K., & Carlberg-Racich, S. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n03_11 · Cited by 242 · see citing works
Brugal, M. T., Domingo‐Salvany, A., Puig, R., Barrio, G., García de Olalla, P., & De La Fuente, L. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01089.x · Cited by 228 · see citing works
Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M., Salamina, G., Diecidue, R., Vigna‐Taglianti, F., Faggiano, F., et al. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02025.x · Cited by 220 · see citing works
Lugo, R. A., Satterfield, K., & Kern, S. E. (2005) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v19n04_05 · Cited by 208 · see citing works
Exposure to opioid maintenance treatment reduces long‐term mortality
Gibson, A., Degenhardt, L. J., Mattick, R. P., Ali, R. L., White, J. M., & O’Brien, S. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02090.x · Cited by 194 · see citing works
Wagner, K. D., Valente, T. W., Casanova, M., Partovi, S. M., Mendenhall, B. M., Hundley, J. H., Gonzalez, M., & Unger, J. B. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.01.003 · Cited by 192 · see citing works
Green, T. C., Heimer, R. R., & Grau, L. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02182.x · Cited by 192 · see citing works
Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
Enteen, L., Bauer, J., McLean, R., Wheeler, E., Huriaux, E., Kral, A. H., & Bamberger, J. D. (2010) · Journal of Urban Health · doi:10.1007/s11524-010-9495-8 · Cited by 185 · see citing works
Hospitalizations for Poisoning by Prescription Opioids, Sedatives, and Tranquilizers
Coben, J. H., Davis, S. M., Furbee, P. M., Sikora, R., Tillotson, R. D., & Bossarte, R. M. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.01.022 · Cited by 173 · see citing works
Identifying Injection Drug Users at Risk of Nonfatal Overdose
Coffin, P. O., Tracy, M., Bucciarelli, A., Ompad, D. C., Vlahov, D., & Galea, S. (2007) · Academic Emergency Medicine · doi:10.1197/j.aem.2007.04.005 · Cited by 161 · see citing works
Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes
Dettmer, K., Saunders, B., & Strang, J. (2001) · BMJ · doi:10.1136/bmj.322.7291.895 · Cited by 158 · see citing works
Bennett, A. S., Bell, A., Tomedi, L. E., Hulsey, E. G., & Kral, A. H. (2011) · Journal of Urban Health · doi:10.1007/s11524-011-9600-7 · Cited by 158 · see citing works
Tobin, K. E., Sherman, S. G., Beilenson, P. L., Welsh, C., & Latkin, C. A. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.03.002 · Cited by 149 · see citing works
Take‐home naloxone to reduce heroin death
Baca, C. T., & Grant, K. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01259.x · Cited by 137 · see citing works
Methadone Deaths: Risk Factors in Pain and Addicted Populations
Modesto‐Lowe, V., Brooks, D., & Petry, N. M. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1225-0 · Cited by 132 · see citing works
Evaluation of a Naloxone Distribution and Administration Program in New York City
Piper, T. M., Stancliff, S., Rudenstine, S., Sherman, S. G., Nandi, V., Clear, A., & Galea, S. (2008) · Substance Use & Misuse · doi:10.1080/10826080701801261 · Cited by 130 · see citing works
Deaths in methadone maintenance treatment in New South Wales, Australia 1990‐1995
ZADOR, D. A., & Sunjic, S. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.951778.x · Cited by 121 · see citing works
Buster, M. C. A., van Brussel, G. H. A., & van den Brink, W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00179.x · Cited by 117 · see citing works
Prescription Naloxone: A Novel Approach to Heroin Overdose Prevention
Sporer, K. A., & Kral, A. H. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.05.025 · Cited by 117 · see citing works
Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines
Caplehorn, J. R. M., & Drummer, O. H. (2002) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2002.tb00185.x · Cited by 112 · see citing works
Determinants of overdose incidents among illicit opioid users in 5 Canadian cities
Fischer, B. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031416 · Cited by 102 · see citing works
Cousins, G., Teljeur, C., Motterlini, N., McCowan, C., Dimitrov, B. D., & Fahey, T. P. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.05.001 · Cited by 101 · see citing works
Rowlingson, J. C. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200301000-00076 · Cited by 97 · see citing works
Consensus guideline on parenteral methadone use in pain and palliative care
Shaiova, L., Berger, A. M., Blinderman, C. D., Bruera, E. D., Davis, M. P., Derby, S., Inturrisi, C. E., Kalman, J., Mehta, D., Pappagallo, M., et al. (2008) · Palliative & Supportive Care · doi:10.1017/s1478951508000254 · Cited by 89 · see citing works
Caplehorn, J. R. M. (1998) · Drug and Alcohol Review · doi:10.1080/09595239800187551 · Cited by 81 · see citing works
Methadone: To ECG or Not to ECG…That Is Still the Question
Cruciani, R. A. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.11.003 · Cited by 75 · see citing works
Legal aspects of providing naloxone to heroin users in the United States
Burris, S. C., Norland, J., & Edlin, B. R. (2001) · International Journal of Drug Policy · doi:10.1016/s0955-3959(01)00080-9 · Cited by 75 · see citing works
Strang, J., Best, D. W., Man, L.-H., Noble, A., & Gossop, M. (2000) · International Journal of Drug Policy · doi:10.1016/s0955-3959(00)00070-0 · Cited by 69 · see citing works
Increase in Deaths Due to Methadone in North Carolina
Ballesteros, M. F., Budnitz, D. S., Sanford, C. P., Gilchrist, J., Agyekum, G. A., & Butts, J. D. (2003) · JAMA · doi:10.1001/jama.290.1.40 · Cited by 68 · see citing works
Illicit use of methadone among IV drug users in Montreal
Lauzon, P., Vincelette, J., Bruneau, J., Lamothe, F., Lachance, N., Brabant, M., & Soto, J. C. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90099-x · Cited by 41 · see citing works
Methadone- and Heroin-Related Deaths in Florida
Graham, N. A., Merlo, L. J., Goldberger, B. A., & Gold, M. S. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802010892 · Cited by 36 · see citing works
Opioid Harm Reduction Strategies: Focus on Expanded Access to Intranasal Naloxone
Wermeling, D. P. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.7.627 · Cited by 31 · see citing works
Methadone induction doses: are our current practices safe?
Srivastava, A., & Kahan, M. (2006) · PubMed · doi:10.1300/j069v25n03_02 · Cited by 27 · see citing works
Maine Drug-Related Mortality Patterns: 1997-2002
Sorg, M. H., & Greenwald, M. S. (2002) · PsycEXTRA Dataset · doi:10.1037/e642382007-001 · Cited by 20 · see citing works
Correlates of illicit methadone use in New York City: A cross-sectional study
Ompad, D. C., Fuller, C. M., Chan, C. A., Frye, V. A., Vlahov, D., & Galea, S. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-375 · Cited by 17 · see citing works
McAuley, A., & FORSYTH, A. J. M. (2010) · Journal of Substance Use · doi:10.3109/14659891.2010.487555 · Cited by 15 · see citing works
Flagged first, then by citations
2 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality
Kleinman, M. E., Brennan, E. E., Goldberger, Z. D., Swor, R. A., Terry, M., Bobrow, B. J., Gazmuri, R. J., Travers, A. H., & Rea, T. D. (2015) · Circulation · doi:10.1161/cir.0000000000000259 · Cited by 880 · see citing works
Medication-Assisted Treatment of Opioid Use Disorder
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 577 · see citing works
A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000034 · Cited by 490 · see citing works
McDonald, R., & Strang, J. (2016) · Addiction · doi:10.1111/add.13326 · Cited by 472 · see citing works
Naloxone dosage for opioid reversal: current evidence and clinical implications
Lynn, R. R., & Galinkin, J. L. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617744161 · Cited by 353 · see citing works
Part 3: Adult Basic Life Support and Automated External Defibrillation
Travers, A. H., Perkins, G. D., Berg, R. A., Castrén, M. K., Considine, J., Escalante, R., Gazmuri, R. J., Koster, R. W., Lim, S. H., Nation, K. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000272 · Cited by 342 · see citing works
Part 10: Special Circumstances of Resuscitation
Lavonas, E. J., Drennan, I. R., Gabrielli, A., Heffner, A. C., Hoyte, C. O., Orkin, A. M., Sawyer, K. N., & Donnino, M. W. (2015) · Circulation · doi:10.1161/cir.0000000000000264 · Cited by 275 · see citing works
Fairbairn, N. S., Coffin, P. O., & Walley, A. Y. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.005 · Cited by 275 · see citing works
Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.001 · Cited by 272 · see citing works
Unick, G. J., Rosenblum, D., Mars, S. G., & Ciccarone, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054496 · Cited by 255 · see citing works
Cheng, A., Magid, D. J., Auerbach, M. A., Bhanji, F., Bigham, B. L., Blewer, A. L., Dainty, K. N., Diederich, E., Lin, Y., Leary, M., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000903 · Cited by 259 · see citing works
Part 3: Adult basic life support and automated external defibrillation
Perkins, G. D., Travers, A. H., Berg, R. A., Castrén, M. K., Considine, J., Escalante, R., Gazmuri, R. J., Koster, R. W., Lim, S. H., Nation, K. J., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.041 · Cited by 219 · see citing works
Mueller, S. R., Walley, A. Y., Calcaterra, S. L., Glanz, J. M., & Binswanger, I. A. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1010032 · Cited by 193 · see citing works
Lavonas, E. J., Akpunonu, P. D., Arens, A. M., Babu, K. M., Cao, D., Hoffman, R. S., Hoyte, C. O., Mazer-Amirshahi, M. E., Stolbach, A., St-Onge, M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001161 · Cited by 189 · see citing works
Doe-Simkins, M., Quinn, E. K., Xuan, Z., Sorensen-Alawad, A., Hackman, H., Ozonoff, A., & Walley, A. Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-297 · Cited by 175 · see citing works
Wermeling, D. P. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614564776 · Cited by 164 · see citing works
Winhusen, T. M., Walley, A. Y., Fanucchi, L. C., Hunt, T., Lyons, M., Lofwall, M. R., Brown, J. L., Freeman, P. R., Nunes, E. V., Beers, D., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108325 · Cited by 133 · see citing works
A systematic review of the cardiotoxicity of methadone.
Alinejad, S., Kazemi, T., Zamani, N., Hoffman, R. S., & Mehrpour, O. (2015) · EXCLI journal · doi:10.17179/excli2015-553 · Cited by 113 · see citing works
Krieter, P. A., Chiang, N., Gyaw, S., Skolnick, P., Crystal, R., Keegan, F., Aker, J., Beck, M., & Harris, J. J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.759 · Cited by 111 · see citing works
Bachhuber, M. A., McGinty, E. E., Kennedy‐Hendricks, A., Niederdeppe, J., & Barry, C. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130050 · Cited by 90 · see citing works
Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer
Arthur, J. A., & Bruera, E. D. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0143-7 · Cited by 90 · see citing works
Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
Lim, J. K., Bratberg, J. P., Davis, C. S., Green, T. C., & Walley, A. Y. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000223 · Cited by 82 · see citing works
Changing Law from Barrier to Facilitator of Opioid Overdose Prevention
Davis, C. S., Webb, D., & Burris, S. C. (2013) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12035 · Cited by 78 · see citing works
Drainoni, M., Koppelman, E. A., Feldman, J. A., Walley, A. Y., Mitchell, P. M., Ellison, J. E., & Bernstein, E. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2268-z · Cited by 73 · see citing works
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose
Dietze, P., JAUNCEY, M. E., Salmon, A. M., Mohebbi, M., Latimer, J., van Beek, I., McGrath, C., & Kerr, D. C. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14977 · Cited by 61 · see citing works
Mauri, A. I., Townsend, T., & Haffajee, R. L. (2019) · Milbank Quarterly · doi:10.1111/1468-0009.12436 · Cited by 60 · see citing works
2024 American Heart Association and American Red Cross Guidelines for First Aid
Brumberg, E. K. H., Douma, M. J., Alibertis, K., Charlton, N. P., Goldman, M. P., Harper-Kirksey, K., Hawkins, S. C., Hoover, A. V., Kule, A., Leichtle, S. W., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001281 · Cited by 72 · see citing works
Allen, S. T., O’Rourke, A., Johnson, J. A., Cheatom, C., Zhang, Y., Delise, B., Watkins, K., Reich, K., Reich, R. R., & Lockett, C. T. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2121418 · Cited by 58 · see citing works
Oxytocin under opioid antagonism leads to supralinear enhancement of social attention
Dal Monte, O., Piva, M., Anderson, K. M., Tringides, M., Holmes, A. J., & Chang, S. W. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702725114 · Cited by 55 · see citing works
Bazazi, A. R., Zelenev, A., Fu, J. J., Yee, I., Kamarulzaman, A., & Altice, F. L. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.11.010 · Cited by 56 · see citing works
Lewis, C., Vo, H. T., & Fishman, M. J. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s101700 · Cited by 54 · see citing works
Endogenous opiates and behavior: 2013
Bodnar, R. J. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.013 · Cited by 52 · see citing works
Strang, J., McDonald, R., Alqurshi, A. A., Royall, P. G., Taylor, D. M., & Forbes, B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.042 · Cited by 51 · see citing works
Treating Addictions: Harm Reduction in Clinical Care and Prevention
Drucker, E., Anderson, K., Haemmig, R., Heimer, R., Small, D., Walley, A., Wood, E., & van Beek, I. (2016) · Journal of Bioethical Inquiry · doi:10.1007/s11673-016-9720-6 · Cited by 49 · see citing works
Canadian Guidelines on Opioid Use Disorder Among Older Adults
Rieb, L. M., Samaan, Z., Furlan, A. D., Rabheru, K., Feldman, S., Hung, L., Budd, G., & Coleman, D. (2020) · Canadian Geriatrics Journal · doi:10.5770/cgj.23.420 · Cited by 49 · see citing works
Expanding access to naloxone for family members: The Massachusetts experience
Bagley, S. M., Forman, L. S., Ruiz, S., Cranston, K., & Walley, A. Y. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12551 · Cited by 46 · see citing works
Strengths and weaknesses of existing data sources to support research to address the opioids crisis
Smart, R., Kase, C., Taylor, E. A., Lumsden, S., Smith, S. R., & Stein, B. D. (2019) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2019.101015 · Cited by 45 · see citing works
Expanding access to naloxone in the United States
Doyon, S., Aks, S. E., & Schaeffer, S. E. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.968657 · Cited by 40 · see citing works
Kim, H., Connors, N. J., & Mazer-Amirshahi, M. E. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1613372 · Cited by 37 · see citing works
Strang, J., McDonald, R., Tas, B., & Day, E. (2016) · Addiction · doi:10.1111/add.13209 · Cited by 38 · see citing works
Expanding Access to Naloxone in the United States
Doyon, S., Aks, S. E., & Schaeffer, S. E. (2014) · Journal of Medical Toxicology · doi:10.1007/s13181-014-0432-1 · Cited by 37 · see citing works
Berland, N., Lugassy, D. M., Fox, A. D., Goldfeld, K. S., Oh, S.-Y., Tofighi, B., & Hanley, K. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1572048 · Cited by 37 · see citing works
Thakarar, K., Weinstein, Z., & Walley, A. Y. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133720 · Cited by 34 · see citing works
Why aren’t Australian pharmacists supplying naloxone? Findings from a qualitative study
Olsen, A., Lawton, B., Dwyer, R., Taing, M., Chun, K. L. J., Hollingworth, S., & Nielsen, S. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.03.020 · Cited by 34 · see citing works
Retention of Student Pharmacists’ Knowledge and Skills regarding Overdose Management with Naloxone
Jacobson, A. N., Bratberg, J. P., Monk, M., & Ferrentino, J. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1439797 · Cited by 33 · see citing works
Bascou, N. A., Haslund-Gourley, B. S., Amber-Monta, K., Samson, K. R., Goss, N. C., Meredith, D. M., Friedman, A. V., Needleman, A., Kumar, V. K., & Fischer, B. D. (2022) · Harm Reduction Journal · doi:10.1186/s12954-022-00589-6 · Cited by 32 · see citing works
Assembling the Social and Political Dimensions of Take-Home Naloxone
Farrugia, A., Fraser, S., & Dwyer, R. (2017) · Contemporary Drug Problems · doi:10.1177/0091450917723350 · Cited by 31 · see citing works
Dwyer, R., Fraser, S., & Dietze, P. (2016) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2016.1150964 · Cited by 30 · see citing works
Thylstrup, B., Seid, A. K., Tjagvad, C., & Hesse, M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107714 · Cited by 28 · see citing works
Take-home naloxone possession among people who inject drugs in rural West Virginia
Allen, S. T., White, R. H., O’Rourke, A., Grieb, S. M. D., Kilkenny, M. E., & Sherman, S. G. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107581 · Cited by 27 · see citing works
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting
Ataiants, J., Roth, A. M., Mazzella, S., & Lankenau, S. E. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102691 · Cited by 28 · see citing works
Spatial Methods to Enhance Public Health Surveillance and Resource Deployment in the Opioid Epidemic
Dodson, Z. M., Yoo, E.-H. E., Martin‐Gill, C., & Roth, R. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304524 · Cited by 27 · see citing works
Lessons Learned from the Expansion of Naloxone Access in Massachusetts and North Carolina
Davis, C. S., Walley, A. Y., & Bridger, C. (2015) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12208 · Cited by 24 · see citing works
Lim, J. K., Forman, L. S., Ruiz, S., Xuan, Z., Callis, B. P., Cranston, K., & Walley, A. Y. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.033 · Cited by 24 · see citing works
Is a Prehospital Treat and Release Protocol for Opioid Overdose Safe?
Kolinsky, D. C., Keim, S. M., Cohn, B. G., Schwarz, E. S., & Yealy, D. M. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.09.015 · Cited by 24 · see citing works
Pharmaceutical opioid overdose deaths and the presence of witnesses
Ogeil, R. P., Dwyer, J., Bugeja, L. C., Heilbronn, C., Lubman, D. I., & Lloyd, B. K. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.12.020 · Cited by 23 · see citing works
Novel Interventions to Prevent HIV and HCV Among Persons Who Inject Drugs
Coffin, P. O., Rowe, C. L., & Santos, G. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0248-2 · Cited by 21 · see citing works
Chichester, K. R., Drawve, G. R., Giménez-Santana, A., Sisson, M. L., McCleskey, B. C., Dye, D. W., Walker, J. T., Mrug, S., & Cropsey, K. L. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102736 · Cited by 19 · see citing works
Wright, Q. E., Higginbotham, S. K., Bunk, E., & Covvey, J. R. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.11.027 · Cited by 17 · see citing works
Thylstrup, B., Hesse, M., Jørgensen, M., & Thiesen, H. (2019) · Harm Reduction Journal · doi:10.1186/s12954-019-0328-0 · Cited by 17 · see citing works
Acute Poisoning with Methadone (Dolphin) (Review)
Александрович, Л. Г., Тариэлович, Л. А., Васильевич, Б. Б., Lodyagin, A. N., Глушков, С. И., Kharitonova, T. V., Ivanova, A. A., Baranov, D. V., & Антонова, А. М. (2017) · General Reanimatology · doi:10.15360/1813-9779-2017-3-48-63 · Cited by 14 · see citing works
Bagley, S. M., Cabral, H., Saia, K., Brown, A., Lloyd-Travaglini, C. A., Walley, A. Y., & Jacobs, R. R. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0126-0 · Cited by 14 · see citing works
Antoniou, T., Martins, D., Campbell, T. J., Tadrous, M., Munro, C., Leece, P., Mamdani, M., Juurlink, D. N., & Gomes, T. (2020) · Addiction · doi:10.1111/add.15324 · Cited by 14 · see citing works
Buprenorphine Treatment Intake and Critical Encounters following a Nonfatal Opioid Overdose
Victor, G. A., Bailey, K., & Ray, B. R. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1901933 · Cited by 13 · see citing works
Marotta, P. L., & McCullagh, C. A. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0342-z · Cited by 12 · see citing works
Stein, B. D., Jones, C. M., Smart, R., Sheng, F., & Sorbero, M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108569 · Cited by 12 · see citing works
Natale, I., Harvey, C., Wood, P. J., & Anderson, K. (2023) · Qualitative Research in Medicine & Healthcare · doi:10.4081/qrmh.2023.10868 · Cited by 12 · see citing works
Doyon, S., Benton, C., Anderson, B. A., Baier, M., Haas, E. E., Hadley, L., Maehr, J., Rebbert‐Franklin, K., Olsen, Y. K., & Welsh, C. (2016) · American Journal on Addictions · doi:10.1111/ajad.12384 · Cited by 12 · see citing works
Spatial and neighborhood-level correlates of lay naloxone reversal events and service availability
Yi, G. T., Dayton, L., Uzzi, M., Browne, K., Konstantopoulos, A. D., & Latkin, C. A. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103739 · Cited by 10 · see citing works
Sellen, K., Markowitz, B., Parsons, J. A., Leece, P., Handford, C. D., Goso, N., Hopkins, S., Klaiman, M., Shahin, R., Milos, G., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-15554-6 · Cited by 9 · see citing works
Wilder, C. M., Brason, F. W., Clark, A. K., Galanter, M. S., Walley, A. Y., & Winstanley, E. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000032 · Cited by 9 · see citing works
Baldacchino, A., Crocamo, C., Humphris, G. M., Neufeind, J., Frisher, M., Scherbaum, N., & Carrà, G. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.05.018 · Cited by 8 · see citing works
Who is Overdosing? An Updated Picture of Overdose Deaths From 2008 to 2015
Eigner, G., Henriksen, B. S., Huynh, P., Murphy, D., Brubaker, C., Sanders, J., & McMahan, D. A. (2017) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817727424 · Cited by 9 · see citing works
Arthur, J. A., & Reddy, A. S. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0636-3 · Cited by 9 · see citing works
Dietze, P., & Cantwell, K. (2016) · Addiction · doi:10.1111/add.13260 · Cited by 8 · see citing works
Process evaluation of the Prevent Overdose in Toronto (POINT) program
Leece, P., Gassanov, M. A., Hopkins, S., Marshall, C., Millson, P. E., & Shahin, R. (2016) · Canadian Journal of Public Health · doi:10.17269/cjph.107.5480 · Cited by 6 · see citing works
Swartz, J. A., Lin, Q., & Kim, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271418 · Cited by 4 · see citing works
Tin, Y., Castry, M., Bowers-Sword, R., Shantharam, S., Aldridge, A., Zarkin, G. A., Starbird, L. E., Linas, B. P., Barocas, J. A., & Morgan, J. R. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001218 · Cited by 4 · see citing works
Naloxone for Outpatients at Risk of Opioid Overdose #328
Chwistek, M., & Wolf, M. (2017) · Journal of Palliative Medicine · doi:10.1089/jpm.2017.0087 · Cited by 4 · see citing works
Latkin, C. A., Dayton, L., Davey-Rothwell, M. A., & Jones, A. A. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22020213 · Cited by 3 · see citing works
Changing Law from Barrier to Facilitator of Opioid Overdose PreventionPreprint
Davis, C. S., Webb, D., & Burris, S. C. (2013) · SSRN Electronic Journal · doi:10.2139/ssrn.2252624 · Cited by 3 · see citing works
A clinical case of acute methadone poisoning in an infant child
Narzikulov, R. A., Lodyagin, A. N., Sinenchenko, A. G., Batotsyrenov, C. B., Rustamov, B. R., Лисица, И. А., & Zapasnikov, N. D. (2023) · Toxicological Review · doi:10.47470/0869-7922-2023-31-4-237-242 · Cited by 2 · see citing works
Evaluation of an emergency department‐based approach to reduce subsequent opioid overdoses
Reed, E. N., Papp, J., Oh, Y., LeVine, K., Tarabichi, Y., Bastian, E., Pollock, K., Wilson, L. D., Siff, J. E., & Piktel, J. S. (2024) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.13304 · Cited by 2 · see citing works
Sloan, P. A., Davis, M. P., & Garnier, P. (2014) · Journal of Opioid Management · doi:10.5055/jom.2014.0233 · Cited by 2 · see citing works
Davis, M. P., Gamier, P., & Sloan, P. A. (2023) · Journal of Opioid Management · doi:10.5055/jom.2014.0229 · Cited by 2 · see citing works
Intravenous Use of Intranasal Naloxone: A Case of Overdose Reversal
Das, S., Shah, N. G., & Ghadiali, M. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1267686 · Cited by 2 · see citing works
Gicquelais, R. E., Bohnert, A. S. B., & Fernandez, A. C. (2020) · Substance Abuse · doi:10.1080/08897077.2020.1784361 · Cited by 2 · see citing works
Wygonik, Q. R., Glassman, T., & Tucker‐Gail, K. (2021) · Journal of Drug Issues · doi:10.1177/00220426211006365 · Cited by 2 · see citing works
Commentary on Pierce et al. (2016): Raising the bar of addiction treatment—first do no harm
Banta‐Green, C. J., & Coffin, P. O. (2016) · Addiction · doi:10.1111/add.13228 · Cited by 2 · see citing works
Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown
Siemens, J.-M. A., Bhoora, U., & van Rensburg, M. N. S. J. (2023) · South African Family Practice · doi:10.4102/safp.v65i1.5708 · Cited by 1 · see citing works
Zarei, M. J., Ramezani, M., Sahraie, Z., Shadnia, S., Evini, P. E. T., Mostafazadeh, B., & Rahimi, M. (2023) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v11i1.2047 · Cited by 1 · see citing works
Tait, R. J., & Lenton, S. R. (2014) · Addiction · doi:10.1111/add.12396
Review article: A SYSTEMATIC REVIEW OF THE CARDIOTOXICITY OF METHADONE
Alinejad, S., Kazemi, T., Zamani, N., Hoffman, R. S., Mehrpour, O., & Pereleman, R. O. (2015)
The Adoption Of Harm Reduction By Abstinence Program Staff: A Qualitative Analysis
Coe, M. (2021) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/8498410
A Feasibility Study of a Group-based Opioid Overdose Prevention Educational Intervention
Clark, A. K. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Willis, A. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1204
Low-energy Bluetooth for Detecting Real-world Penetrance of Bystander Naloxone Kits: A Pilot Study
Lai, J. T., Chapman, B. P., Boyle, K. L., Boyer, E. W., & Chai, P. R. (2018) · Hawaii International Conference on System Sciences (HICSS) · doi:10.24251/hicss.2018.411
Sellen, K., Markowitz, B., Goso, N., Mulvale, A., Hunt, R., Handford, C. D., Klaiman, M., Wright, A., Charles, M., Sniderman, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-978690/v1
Formation sur la naloxone en clinique de médecine familiale, une mesure prometteuse
Grégoire, A. I., St-Pierre, K. L., Racine-Hemmings, F., Voisine, G., Courtois, E. B., Brunet, C., Marois-Pagé, E., Loslier, J., Williams, R., Berbiche, D., et al. (2021) · Drogues santé et société · doi:10.7202/1085174ar
Swartz, J. A., Lin, Q., & Kim, Y. (2022) · medRxiv · doi:10.1101/2022.07.01.22277147
- Authors
- Walley, A. Y., Doe-Simkins, M., Quinn, E., Pierce, C., Xuan, Z., & Ozonoff, A.
- Affiliations
- Boston University (US)
- Boston Children's Hospital (US)
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 44
- Issue
- 2
- Pages
- 241-247
- ISSN
- 0740-5472 (ISSN-L)
- OpenAlex
- W1979851403
- Cited by
- 107
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 10 · 2013: 3
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Substance Abuse Treatment (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (1R21CE001602-02)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- opioid overdose prevention, intranasal naloxone, overdose education and naloxone distribution, methadone maintenance treatment, opioid use disorder, overdose risk factors, inpatient detoxification, HIV prevention programs, polydrug use, prison history, public health interventions
- MeSH terms
- Administration, Intranasal, Adult, Female, Humans, Male, Massachusetts, Methadone, Middle Aged, Naloxone, Narcotic Antagonists, Opioid-Related Disorders, Narcotics, Patient Education as Topic, Pilot Projects, Risk Factors, Substance Withdrawal Syndrome, HIV Infections, Young Adult, Opiate Substitution Treatment, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review